Netflix Swings After Reporting… And Trump Takes Aim At Powell 4/17/25
CNBC's "Fast Money"
Market Impact of Upcoming Obesity and Diabetes Treatment
This chapter explores the anticipated launch of a new oral medication aimed at combating obesity and diabetes, projected to hit the market next year. It also addresses the implications for Novo Nordisk’s stock performance and the investor sentiment surrounding the medication's potential market reach.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
